Concepedia

Publication | Open Access

Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

DOIFull Paper Access

205

Citations

10

References

2013

Year

Raymond T. Bartus, Tiffany Baumann, João Siffert, Christopher D. Herzog, Ron L. Alterman, Nicholas M. Boulis, Dennis A. Turner, Mark Stacy, Anthony E. Lang, Andrés M. Lozano,
Neurology

Abstract

This study provides Class IV evidence that bilateral neurturin gene delivery (CERE-120) to the SN plus putamen in patients with moderately advanced PD is feasible and safe.

References

YearCitations

Page 1